Head and Neck Cancer

  • Samuel G. TaylorIV
  • Katherine Griem
Part of the Medical Radiology book series (MEDRAD)


Cisplatin has been an important addition to the treatment of head and neck cancer. It is the only drug to have been proven to cause a survival benefit when compared with supportive care alone in the palliative management of advanced head and neck cancer (Morton et al. 1985). It has interesting radiation-sensitizing properties in some systems and it is part of the most active drug combination in head and neck cancer when combined with 5-ftuorouracil infusion. In comparison with the newer analogs of carboplatin and iproplatin, cisplatin has the highest tumor cell uptake of the platinates when given parenterally ( al. 1987).


Clin Oncol Neck Cancer Induction Chemotherapy Advanced Head Cerebral Vascular Accident 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adelstein D, Sharan V, Earle A et al. (1988) Simultaneous radiotherapy and chemotherapy with 5-fluorouracil and cisplatin for locally confined squamous cell head and neck cancer. NCI Monogr 6: 347–351PubMedGoogle Scholar
  2. Al-Sarraf M, Weaver A, Peppard S et al. (1980) High dose cis-platinum and 5-fluorouracil infusion as part of a multidisciplinary therapeutic approach for advanced previously untreated epidermoid cancers of the head and neck. In: Abstracts, International Head and Neck Oncology Research Conference, vol II. Nat! Cancer Inst,Rosslyn, VA, P 15Google Scholar
  3. Al-Sarraf M, Pajak TF, Marcial VA et al. (1987) Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. Cancer 59: 259–265PubMedCrossRefGoogle Scholar
  4. Alvarez MV, Cobreeros G, Heras A et al. (1978) Studies on cis dichlorodiammineplatinum (II) as a radiosensitizer.Br J Cancer 37: 68–72Google Scholar
  5. Bagshaw MA (1961) Possible role of potentiators in radiation therapy. AJR 85: 822–833Google Scholar
  6. Bloom EJ, Green MO, Cooper JS et al. (1985) Concomitant use of cis-platinum (CDDP) chemotherapy and radiation therapy (RT) in the treatment of advanced head and neck cancer. In: Foti M, Mennite MA, Pusztay HM (eds) Proc Am Soc Clin Oncol. Waverly,Baltimore, p137Google Scholar
  7. Bolla M, Borgel J, Guenoun A et al. (1988) Chemotherapy with low doses of radiation followed by definitive radiotherapy for advanced unresectable carcinoma of the headekneck. NCI Monogr 6: 357–359PubMedGoogle Scholar
  8. Byfield JE, Barone RM, Mendelsohn J (1980) Infusional 5-fluouracil and x-ray therapy for non-resectable esophageal cancer. Cancer 45: 703–708PubMedCrossRefGoogle Scholar
  9. Byfield JE, Calabro-Jones PM, Klisak I et al. (1982) Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-ftuorouracil or ftorafur and x-rays. Int J Radiat Oncol Bioi Phys 8:1923–1933CrossRefGoogle Scholar
  10. Chang H, Leone LA, Tefft M, Nigri PT (1988) Advanced head and neck cancer: response to and toxicity of multimodality therapy. Radiology 168: 863–867PubMedGoogle Scholar
  11. Coughlin CT, Richmond RC (1985) Platinum based combined modality approach for locally advanced head neck carcinoma. Int J Radiat Oncol Bioi Phys 22: 915CrossRefGoogle Scholar
  12. Creagan ET, Fountan KS, Frytak S et al. (1981) Concomitant radiation therapy and cis-diamminedichloroplatinum (II) in patients with advanced head and neck cancer. Med Pediatr Oncol 9: 119–120PubMedCrossRefGoogle Scholar
  13. Dionet C, Rozan R, Achard JL et al. (1988) Sequential combination of 5-ftuorouracil, cis-platinum and irradiation: advanced head and neck cancers. Radiat Oncol11: 123–131Google Scholar
  14. Douple EB, Richmond RC (1979) Radiosensitization of hypoxic tumour cells by cis- and trans-dichlorodiammineplatinum (II). Int J Radiat Oncol Bioi Phys 5: 1369–1372Google Scholar
  15. Dritsschilo A, Piro AJ, Kelman AD (1979) The effect of cis-platinum on the repair of radiation damage in plateau phase Chinese hamster (V-79) cells. lnt J Radiat Oncol Bioi Phys 5: 1345–1349Google Scholar
  16. Forestiere AA, Belliveau JF, Goren MP et al. (1988) Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum (II) in head and neck cancer patients. Cancer Res 48: 3869–3874Google Scholar
  17. Haselow RE, (1988) Presentation on integrated chemotherapy- radiation therapy to the Second Int Conf Head and Neck Cancer. DR Goffinet, moderator. Boston,MAGoogle Scholar
  18. Hecquet B, Caty A, Fournier C et al. (1987) Comparison of platinum concentrations in human head and neck tumors following administration of carboplatin, iproplatin, or cisplatin. Bull Cancer 74: 433–436PubMedGoogle Scholar
  19. High M, Heuser L, Schmidt CH et al. (1983) Simultane cisplatin- und bestrahlungstherapie lokal fortgeschrittener plattenepithelkarzinome der Kopf-Hals-Region. Dtsch Med Wochenschr 46: 1743CrossRefGoogle Scholar
  20. Hong WK, Wolf GT, Fisher S et al. (1989) Laryngeal preservation with induction chemotherapy and radiotherapy in the treatment for advanced laryngeal cancer: fnterim survival data of vacsp 268, VA laryngeal cancer study group. Am: Soc Clin Oncol 8: 167Google Scholar
  21. Jacobs C, Bertino JR, Goffinet DR et al. (1978) Twentyfour- hour infusion of cis-platinum in head and neck cancer. Cancer 42: 2135–2140PubMedCrossRefGoogle Scholar
  22. Jacobs C, Goffinet DR, Goffinet L et al. (1987) Chemotherapy as a substitute for surgery in the treatment of advanced head and neck cancer. Cancer 60:1178–1183PubMedCrossRefGoogle Scholar
  23. Jacobs JR, Weaver A, Ahmed K et al. (1987) Protochemotherapy in advanced head and neck cancer. Head Neck Surg 10: 93–98PubMedCrossRefGoogle Scholar
  24. McDonald S, Mills EED, van der Merwe AM et al. (1987) Simultaneous radiation therapy and cisplatin chemotherapy in advanced cancer of the head and neck. Am J Clin Oncol (CCT) 10: 410–416CrossRefGoogle Scholar
  25. Merlano M, Rosso R, Sertoli MR et al. (1988a) Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study. J Clin Oncol 6: 627–632PubMedGoogle Scholar
  26. Merlano M, Grimaldi A, Benasso M et al. (1988b) Alternating cisplatin-5-ftuorouracil plus radiation in head and neck cancer. NCl Monogr 6: 343–345Google Scholar
  27. Morton RP, Rugman F, Dorman EB et al. (1985) Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial. Cancer Chemother Pharmacol 15: 283–289PubMedCrossRefGoogle Scholar
  28. Richmond RC, Powers EL (1976) Radiation sensitization of bacterial spores by cis-dichlorodiammineplatinum (II). Radiat Res 68: 20–23CrossRefGoogle Scholar
  29. Schwarz JL, Rotmensch J, Beckett MA et al. (1988) x-ray and cis diamminedichloroplatinum (II) cross-resistance in human tumor cell clones. Cancer Res 48: 5133–5135Google Scholar
  30. Siotman GJ, Cummings FJ, Glicksman AR et al. (1986) Preoperative simultaneously administered cis-platinum plus radiation therapy for advanced squamous cell carcinoma of carcinoma of the head and neck. Head NeckSurg 8: 159–164CrossRefGoogle Scholar
  31. Snydermann NL, Wetmore SJ, Suen JY (1986)Cisplatin sensitization to radiotherapy in stage IV squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 112:1147–1150CrossRefGoogle Scholar
  32. Taylor SG IV, Murthy AK, Showel JL et al. (1985) Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5-FU chemotherapy. Cancer Treat Rep 69: 938–939Google Scholar
  33. Taylor SG IV, Murthy AK, Caldarelli DD et al. (1989) Combined, simultaneous cisplatin/5-FU infusion chemotherapy and split course radiation in head and neckcancer. J Clin Oncol, 7: 846–856PubMedGoogle Scholar
  34. Taylor SG IV, Murthy AK, Showel JL et al. Comparison of toxicity in a randomized trial of sequential vs. simultaneous cisplatin/5-FU infusion and radiation therapy in head and neck cancer. Proc Am Soc Clin Oncol, 8: 175,1989Google Scholar
  35. Tobias JS, Smith BJ, Blackman G, Finn G (1987) Concurrent daily cisplatin and radiotherapy in locally advanced squamous carcinoma of the head-and-neck and bronchus. Radiother Oncol 9: 263–268PubMedCrossRefGoogle Scholar
  36. Wallner KE, Li GC (1987) Effect of cisplatin resistance on cellular radiation response. Int J Radiat Oncol Bioi Phys13: 587–591CrossRefGoogle Scholar
  37. Wendt TG, Wustrow TPU, Hartenstein RC et al. (1987) Accelerated split-course radiotherapy and simultaneous cis-dichlorodiammine-platinum and 5-ftuorouracil chemotherapy with folinic acid enhancement for unresectable carcinoma of the head and neck. Radiother Oncol10: 277–284Google Scholar
  38. Wheeler R, Salter M, Stephens S et al. (1988) Simultaneous therapy with high-dose cisplatin and radiation for unresectable squamous cell cancer of the head and neck: a phase I-II study. NCI Monogr 6: 339–341PubMedGoogle Scholar
  39. Zak M, Drobnik J (1971) Effects of cis-dichlorodiammineplatinum (II) on the post-irradiation lethality in mice after irradiation with x-rays. Strahlentherapie 142: 112–115PubMedGoogle Scholar
  40. Zerillo G, Cupido G, Ardizzone S et al. (1986) Funzione radio-sensibilizzante del cis-platino nei carcinomi avanzati della largine. Protocollo combinato chemioradioterapico.Oto-Rino Laringolia 36: 11–14Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Samuel G. TaylorIV
    • 1
  • Katherine Griem
    • 2
  1. 1.Section of Medical OncologyRush-Presbyterian-St. Luke’s Medical CenterChicagoUSA
  2. 2.Rush-Presbyterian-St. Luke’s Medical CenterChicagoUSA

Personalised recommendations